{"id":483156,"date":"2024-07-15T12:40:36","date_gmt":"2024-07-15T10:40:36","guid":{"rendered":"https:\/\/innovationorigins.com\/?p=483156"},"modified":"2024-07-15T12:40:36","modified_gmt":"2024-07-15T10:40:36","slug":"rising-cancer-survival-rates-go-hand-in-hand-with-scientific-innovations","status":"publish","type":"post","link":"https:\/\/ioplus.nl\/archive\/en\/rising-cancer-survival-rates-go-hand-in-hand-with-scientific-innovations\/","title":{"rendered":"Rising cancer survival rates go hand in hand with scientific innovations"},"content":{"rendered":"\n<p>The <a href=\"https:\/\/iknl.nl\/nieuws\/2024\/toegenomen-overleving-2020-2022\">latest data<\/a> from the Netherlands Cancer Registry (NKR) reveals a significant improvement in cancer survival rates over the past two decades. This comprehensive data shows that advancements in treatment methods, innovative medicines, and enhanced diagnostics have substantially increased the chances of survival for cancer patients in the country.<\/p>\n\n\n\n<div class=\"io-block io-block__box\"><h2>Why this is important:<\/h2><p>Enhanced therapies, early detection, and innovative treatment options are leading to higher survival rates for cancer patients, highlighting the importance of continued medical advancements.<\/p><\/div>\n\n\n\n<p>From 2018 to 2022, the five-year survival rate for cancer patients has risen by 2 percentage points, reaching 68%, compared to the previous period of 2013-2017. This means that more than two-thirds of patients diagnosed with cancer during this time are expected to survive at least five years post-diagnosis.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Innovative drugs drive survival improvements<\/h2>\n\n\n\n<p>One of the key factors contributing to these improvements is the introduction of dozens of new drugs over the past decades. Particularly in lung cancer, significant advancements have been noted with the availability of new medications from 2017 onwards.&nbsp;<\/p>\n\n\n\n<p>The Netherlands itself ranks high globally in cancer research and innovation standing at the forefront of developing new cancer treatments. For example, start-up UPyTher has pioneered a novel method for treating peritoneal cancer by injecting chemotherapy into the abdominal cavity in the form of a gel. This gel acts as a depot, gradually releasing the chemotherapy, thereby exposing tumors to the treatment for longer periods and enhancing its effectiveness.&nbsp;<\/p>\n\n\n<div class=\"vlp-link-container vlp-layout-basic wp-block-visual-link-preview-link advgb-dyn-35a359e2\"><a href=\"https:\/\/ioplus.nl\/archive\/en\/upyther-aims-to-make-peritoneal-cancer-treatable-with-a-chemogel\/\" class=\"vlp-link\" title=\"UPyTher aims to make peritoneal cancer treatable with a chemogel\"><\/a><div class=\"vlp-layout-zone-side\"><div class=\"vlp-block-2 vlp-link-image\"><\/div><\/div><div class=\"vlp-layout-zone-main\"><div class=\"vlp-block-0 vlp-link-title\">UPyTher aims to make peritoneal cancer treatable with a chemogel<\/div><div class=\"vlp-block-1 vlp-link-summary\">\u201cOur mission is successful when we can bring effective medication to market, giving patients the prospect of a longer life,\u201d begins Geert van Almen, CEO of UPyTher.<\/div><\/div><\/div>\n\n\n<h2 class=\"wp-block-heading\">Early detection and intervention strategies<\/h2>\n\n\n\n<p>Early detection and better diagnostics also play a crucial role in improving survival rates. Population screenings for cancers such as colon cancer and advanced imaging techniques that facilitate more targeted treatments have made early intervention possible, further boosting survival chances.&nbsp;<\/p>\n\n\n\n<p>Additionally, advancements and innovations in this area further contribute to higher survival rates. Scientists at the Radboud University Medical Center for instance, developed recently a blood test capable to detect the return of blood cancer a year earlier.<\/p>\n\n\n<div class=\"vlp-link-container vlp-layout-basic wp-block-visual-link-preview-link advgb-dyn-de9395a0\"><a href=\"https:\/\/ioplus.nl\/archive\/en\/new-blood-test-spots-returning-blood-cancer-earlier\/\" class=\"vlp-link\" title=\"New blood test spots returning blood cancer earlier\"><\/a><div class=\"vlp-layout-zone-side\"><div class=\"vlp-block-2 vlp-link-image\"><\/div><\/div><div class=\"vlp-layout-zone-main\"><div class=\"vlp-block-0 vlp-link-title\">New blood test spots returning blood cancer earlier<\/div><div class=\"vlp-block-1 vlp-link-summary\">A new blood test can detect the return of blood cancer a year earlier than current standards. <\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>The latest data from the Netherlands Cancer Registry (NKR) reveals a significant improvement in cancer survival rates over the past two decades. This comprehensive data shows that advancements in treatment methods, innovative medicines, and enhanced diagnostics have substantially increased the chances of survival for cancer patients in the country. From 2018 to 2022, the five-year [&hellip;]<\/p>\n","protected":false},"author":2595,"featured_media":506863,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[83907],"tags":[47394,47396],"location":[],"article_type":[36684],"serie":[],"archives":[],"internal_archives":[],"reboot-archive":[82868],"class_list":["post-483156","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bio-en","tag-cancer-detection","tag-cancer-research","article_type-news","reboot-archive-bio"],"blocksy_meta":[],"acf":{"subtitle":"Advancements in treatments, innovative drugs, and early detection have significantly increased cancer survival rates in the Netherlands.","text_display_homepage":false},"author_meta":{"display_name":"Alma Paunero Martorell","author_link":"https:\/\/ioplus.nl\/archive\/author\/alma-paunero\/"},"featured_img":"https:\/\/ioplus.nl\/archive\/wp-content\/uploads\/2024\/07\/innovationorigins_realistic_cancer_treatment_innovation_techn_f0952910-cfec-4537-a584-a0820bf9299d_2.png","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/ioplus.nl\/archive\/en\/category\/bio-en\/\" class=\"advgb-post-tax-term\">BIO+<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">BIO+<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/ioplus.nl\/archive\/en\/category\/bio-en\/\" class=\"advgb-post-tax-term\">cancer detection<\/a>","<a href=\"https:\/\/ioplus.nl\/archive\/en\/category\/bio-en\/\" class=\"advgb-post-tax-term\">cancer research<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">cancer detection<\/span>","<span class=\"advgb-post-tax-term\">cancer research<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 2 years ago","modified":"Updated 2 years ago"},"absolute_dates":{"created":"Posted on July 15, 2024","modified":"Updated on July 15, 2024"},"absolute_dates_time":{"created":"Posted on July 15, 2024 12:40 pm","modified":"Updated on July 15, 2024 12:40 pm"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/posts\/483156","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/users\/2595"}],"replies":[{"embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/comments?post=483156"}],"version-history":[{"count":0,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/posts\/483156\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/media\/506863"}],"wp:attachment":[{"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/media?parent=483156"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/categories?post=483156"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/tags?post=483156"},{"taxonomy":"location","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/location?post=483156"},{"taxonomy":"article_type","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/article_type?post=483156"},{"taxonomy":"serie","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/serie?post=483156"},{"taxonomy":"archives","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/archives?post=483156"},{"taxonomy":"internal_archives","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/internal_archives?post=483156"},{"taxonomy":"reboot-archive","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/reboot-archive?post=483156"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}